Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:RE:Here's a thought

Hi Kayz88 - see IvanVanBeethovens post: https://stockhouse.com/companies...

September 14, 2023

V.TLT

RE:RE:Here's a thought

He did say "up to 5 million"  - which is to say - "no...

September 14, 2023

V.TLT

Here's a thought

Maybe Theralase management is doing its best to minimize dilution while...

September 14, 2023

V.TLT

Commercial Adstiladrin Treatments for NMIBC Commence

Ferring is going full speed ahead commercializing their FDA approved BCG...

September 13, 2023

V.TLT

RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

Yes it does seem ludicrous. Having an sp of 23 cents CAN at this stage of the...

September 12, 2023

V.TLT

Polish Researchers Cite Rutherrin PDT for Brain Cancer

Photosensitizers for Photodynamic Therapy of Brain Cancers—A Review by...

September 12, 2023

V.TLT

RE:RE:RE:RE:RE:RE:and so we wait

God bless you langosta langosta wrote: Still here, still kicking though I...

September 10, 2023

V.TLT

RE:and so we wait

I would lean more to Explanation 2 than Explanation 1. I'm not sure if...

September 8, 2023

V.TLT

RE:RE:RE:PP Closed

It suggests a continuing high level of confidence among insiders. They...

September 7, 2023

V.TLT

RE:Has TLT applied for BTD or not?

"The Company has submitted a pre-BTD submission to the FDA and based on...

September 7, 2023

V.TLT

TLD1433 mentioned in new URO TODAY article

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Review of Intravesical...

September 6, 2023

V.TLT

RE:RE:RE:RE:My calculations add up to more than current sp !

Very interesting "real world" post. DJDawg wrote: I can comment on...

September 3, 2023

V.TLT

RE:RE:RE:My calculations add up to more than current sp !

Roswell Park uses PDCs off label for various forms of cancer. https://www...

September 3, 2023

V.TLT

RE:RE:450 Day CR rate

Thanks. Taking this into account would mean a 36% 450 day CR rate in 9 months...

September 2, 2023

V.TLT

450 Day CR rate

Looking at the new swimmer's plot - there is 1 CR patient at 360 days...

September 2, 2023

V.TLT

RE:Gearing Back Up - Our Team

It turns out Alexander Macdonald and  Niloofar Najafi have both been at...

August 31, 2023

V.TLT

Gearing Back Up - Our Team

https://theralase.com/about-us/leadership-team/ Dr. Lbiati is finally listed...

August 31, 2023

V.TLT

RE:A CR at 90 days is not really a CR if the cancer returns ,

Galaxym31 wrote: they should say an apparent CR obviously it is NOT a CR . ...

August 31, 2023

V.TLT

RE:RE:RE:RE:RE:RE:TLT treatment = Holy-grail of oncologists

Galaxym31 wrote: Seven years of pre clinical work ok . Theralase is not a...

August 31, 2023

V.TLT

RE:RE:RE:RE:TLT treatment = Holy-grail of oncologists

That's the plan, according to Roger in his recent interview: "...

August 31, 2023

Featured Company